Oticon Real vs Sony CRE-C20
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice
Oticon Real
The Oticon Real is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.8/5, placing it in the top 8% of all prescription hearing aids tested and ranking #4 out of 36 devices in its category. Speech performance is a standout strength. Speech in quiet scores an excellent 4.5/5 on initial fit—0.72 points above the category average—while speech in noise scores 3.0/5, nearly a full point above the category average of 1.96/5. While the speech-in-noise result is above average for the category, it remains mixed in absolute terms at 2.9/5 after tuning, reflecting the inherent challenge of noisy environments for all hearing aids. Music streaming quality starts strong at 4.2/5 on initial fit, though it drops to a mixed 2.8/5 after tuning—still slightly above the category average. Feedback handling scores a solid 4.0/5, which is strong in absolute terms, though it falls 0.71 points below the category average of 4.71/5. Own-voice comfort is mixed at 2.4/5, slightly below the category average. The Oticon Real competes directly with other premium devices like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). It offers versatile connectivity with iPhone and Android streaming plus hands-free capabilities, and supports both rechargeable and disposable batteries. This device is best suited for users prioritizing strong out-of-box speech clarity who want a well-rounded premium hearing aid from a trusted manufacturer.

Sony CRE-C20
The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit